Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

The federal government has provided nearly $5.6 million in funding for five vending machines that will dispense medical-grade opioids in British Columbia, Ontario and Nova Scotia. The machines, called MySafe, are akin to ATMs and allow drug users at risk of overdose to get hydromorphone pills dispensed to them after their palm has been scanned to identify its unique vein pattern.

HO/The Canadian Press

The federal government has provided nearly $3.5-million in funding for vending machines that will dispense a medical-grade opioid to drug users in four cities in an effort to prevent overdose deaths.

Darren Fisher, parliamentary secretary to Health Minister Patty Hajdu, said two machines are located in Vancouver and one each are in Victoria; London, Ont.; and Dartmouth, N.S.

The machines, called MySafe, are similar to ATMs and allow drug users to get hydromorphone pills, a substitute for heroin, dispensed to them after their palm has been scanned to identify them.

Story continues below advertisement

“Safer-supply projects offer people with opioid use disorder a life-saving alternative to the toxic, illegal drug supply, but they are not always convenient and easy to access,” Mr. Fisher said.

He said MySafe allows participants to access a safer drug without fear, shame and stigma, and without contact with anyone, which is all the more essential during the pandemic.

Overdose deaths spiked to a record level in British Columbia last year as COVID-19 precautions closed the Canada-U.S. border, leading to domestic manufacturing of more potent substances often laced with high concentrations of the opioid fentanyl.

Participants in the MySafe program in Vancouver are assessed by a doctor and a baseline urine sample is collected before they can access hydromorphone through the machines, which are bolted to the floor.

Mark Tyndall, an epidemiologist and infectious-disease specialist, began the MySafe project in December, 2017, with the installation of the first machine next to an overdose-prevention site in Vancouver’s Downtown Eastside.

The area is home to North America’s first supervised injection site as well as Crosstown, the continent’s first facility to provide injectable heroin as a therapy for entrenched drug users who have tried multiple methods to quit their habit.

While Crosstown also provides injectable hydromorphone, Dr. Tyndall said the program’s strict regimen requiring users to attend several times a day and use their drugs under supervision is not ideal for people who fear being stigmatized.

Story continues below advertisement

The MySafe program, which now has 20 participants at the initial Vancouver site, allows users to access hydromorphone tablets at their convenience, he said.

“In a very short time, I’ve seen people’s lives change. The ability to get up in the morning and just go and pick up your medications is just revolutionary to many people who have, in many cases, got up in the morning, felt unwell and had to hustle to find their drugs,” said Dr. Tyndall, a former director of the B.C. Centre for Disease Control.

However, he said it’s been “an uphill battle” trying to persuade “skittish” doctors in the Downtown Eastside to prescribe hydromorphone that would be dispensed through a machine instead of by a pharmacy.

Doctors in Victoria and Dartmouth are more open to using MySafe, and a group in London is already using MySafe, Dr. Tyndall said.

“The two machines in Vancouver are going to still be a challenge,” he said of reluctance by prescribers in the city where Mayor Kennedy Stewart has implored the federal government to decriminalize the possession of small amounts of drugs for personal use due to the high number of overdose deaths.

Dr. Tyndall said that at 32 cents for an eight-milligram tablet of hydromorphone, MySafe is a cheap and scalable option for communities after an estimated 20,000 overdose fatalities across Canada in recent years.

Story continues below advertisement

Jen Baker, chair of the Ontario Pharmacists Association, said the province already has remote dispensing locations at pharmacy kiosks, and a system like MySafe could be incorporated to provide hydromorphone for those at risk of overdose.

“I could see how those sorts of locations could be adapted in this harm-reduction model to contain medications for those individuals,” she said.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies